Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Combined Targeting of the Menin-MLL1 Chromatin Complex and FLT3 As a Novel Therapeutic Concept Against NPM1 Mutant or MLL -Rearranged AML with Mutated FLT3

Margarita M. Dzama, MSc, Martha C. Taubert, MSc, Kerstin Kunz, Johanna Rausch, MD, Chun-Wei David Chen, PhD, Annalisa Mupo, PhD, Patricia Hähnel, PhD, Matthias Theobald, MD PhD, Thomas Kindler, MD, Richard P. Koche, PhD, George S. Vassiliou, FRCPath, MRCP, PhD, Scott A. Armstrong, MD PhD, Michael W.M. Kühn, MD

Blood (2019) 134 (Supplement_1): 1441.

https://doi.org/10.1182/blood-2019-122847

Published: 2019

Journal Articles

Ruxolitinib Inhibits Toll-like Receptor or GM-CSF, but Not TREM-1 Mediated Neutrophil Activation

Pamela Aranda Lopez, PhD, Astrid Alflen, MD, Nicole Stadler, Cornelia Schmidt, Thomas Kindler, MD, Matthias Theobald, MD PhD, Markus P. Radsak, MD

Blood (2017) 130 (Supplement 1): 4805.

https://doi.org/10.1182/blood.V130.Suppl_1.4805.4805

Published: 2017

Journal Articles

How to Identify Patients for Treg DLI - Treg Subsets in Gvhd As Biomarker for Successful Treg DLI

Pascal Wölfinger, Lukas Schäfer, Katharina Epp, Matthias Theobald, MD PhD, Tobias Bopp, Eva-Maria Wagner, MD

Blood (2017) 130 (Supplement 1): 1989.

https://doi.org/10.1182/blood.V130.Suppl_1.1989.1989

Published: 2017

Journal Articles

Idelalisib Impairs TREM-1 Mediated Neutrophil Inflammatory Responses

Astrid Alflen, Nicole Stadler, Pamela Aranda Lopez, PhD, Daniel Teschner, MD, Georg Hess, Matthias Theobald, MD PhD, Markus P. Radsak, MD

Blood (2017) 130 (Supplement 1): 3569.

https://doi.org/10.1182/blood.V130.Suppl_1.3569.3569

Published: 2017

Journal Articles

Identification of Baseline Characteristics That Predict Good Outcome of Allogeneic Hematopoietic Cell Transplantation in Young Chronic Lymphocytic Leukemia Patients - a Retrospective Analysis from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation.

Blood (2016) 128 (22): 522.

https://doi.org/10.1182/blood.V128.22.522.522

Published: 2016

Journal Articles

Targeting Aberrant Ncam (neural cell adhesion molecule; CD56) Expression in Acute Myeloid Leukemia

Daniel Sasca, MD, Andrea Schueler, PhD, Jakub Szybinski, Oliver Kriege, MD, Kerstin Kunz, Eva Marie Fehr, MD, Patricia Haehnel, PhD, Wolf Henning Gebhardt, PhD, Gerge Reid, PhD, Matthias Theobald, MD PhD, Lars Bullinger, MD, Thomas Kindler, MD

Blood (2015) 126 (23): 311.

https://doi.org/10.1182/blood.V126.23.311.311

Published: 2015

Journal Articles

Interfering with Arginine Metabolism As a New Treatment Strategy for Multiple Myeloma

Bjoern Jacobi, MD, Lea Stroeher, MS, Nadine Leuchtner, Hakim Echchannaoui, PhD, Alexander Desuki, MD, Lara Kuerzer, Alice Habermeier, Edite Antunes, Eva Amann, John Bomalaski, MD, Closs Ellen, PhD Prof., Matthias Theobald, MD PhD, Markus Munder, MD

Blood (2015) 126 (23): 3005.

https://doi.org/10.1182/blood.V126.23.3005.3005

Published: 2015

Journal Articles

The Impact of NFAT Inhibition on Neutrophil Antifungal Defense and Myelopoiesis in Cyclosporine A Treated and NFATc1 LysM Mice

Daniel Teschner, MD, Christian Michel, MD, Steve Pruefer, PhD, Matthias Theobald, MD PhD, Hansjoerg Schild, PhD Prof., Markus Radsak, MD

Blood (2015) 126 (23): 1007.

https://doi.org/10.1182/blood.V126.23.1007.1007

Published: 2015

Journal Articles

Transcutaneous Immunization with a Solid Nanoscopic Imiquimod Suspension Enhances Tumor Rejection

Pamela Stein, PhD, Karsten Gogoll, PhD, Tanja Peters, PhD, Mark Denny, Stefan Tenzer, PhD, Stefan Stevanovic, PhD, Hansjoerg Schild, PhD Prof., Matthias Theobald, MD PhD, Peter Langguth, Markus Radsak, MD

Blood (2015) 126 (23): 2224.

https://doi.org/10.1182/blood.V126.23.2224.2224

Published: 2015

Journal Articles

Impact of Donor Type on Outcome after Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia Patients: Analysis of the German-Austrian Acute Myeloid Leukemia Study Group (AMLSG)

Blood (2014) 124 (21): 1254.

https://doi.org/10.1182/blood.V124.21.1254.1254

Published: 2014

Journal Articles

Neuroendocrine Regulation Of The IL-27-Dependent Immune Response In Macrophages

Markus Bosmann, MD, Julian Roewe, Dennis Riehl, Matthias Theobald, MD, PhD, Peter A. Ward, MD

Blood (2013) 122 (21): 3460.

https://doi.org/10.1182/blood.V122.21.3460.3460

Published: 2013

Journal Articles

Treatment Results In Acute Myeloid Leukemia Over a Time Period Of 20 Years: Analysis Of The German-Austrian Acute Myeloid Leukemia Study Group (AMLSG)

Blood (2013) 122 (21): 3878.

https://doi.org/10.1182/blood.V122.21.3878.3878

Published: 2013

Journal Articles

Gene Therapy With a High-Affinity Single-Chain p53-Specific TCR Mediates Potent Anti-Tumor Response Without Inducing Gvhd In Vivo

Hakim Echchannaoui, PhD, Jutta Petschenka, PhD student, Edite Antunes, Matthias Theobald, MD, PhD

Blood (2013) 122 (21): 1657.

https://doi.org/10.1182/blood.V122.21.1657.1657

Published: 2013

Journal Articles

Follow Up On CD8-Depleted Donor-Lymphocyte Infusions After T-Cell Depleted Allogeneic Hemopoietic Stem Cell Transplantation

Eva Maria Wagner, MD, Daniela Wehler, MD, Timo Schmitt, MD, Aline N. Lay, Karin Kolbe, MD, Matthias Theobald, MD, PhD, Wolfgang Herr, MD, Ralf G Meyer, MD

Blood (2013) 122 (21): 4526.

https://doi.org/10.1182/blood.V122.21.4526.4526

Published: 2013

Journal Articles

Expression Of FLT3-ITD Dysregulates The DBC1-Sirt1-p53 Signaling and Promotes Therapy Resistance

Daniel Sasca, MD, Patricia Haehnel, PhD, Kaml I.K. Khawaja, Birgit Enders, Lars Bullinger, MD, PhD, Matthias Theobald, MD, PhD, Thomas Kindler, MD

Blood (2013) 122 (21): 3789.

https://doi.org/10.1182/blood.V122.21.3789.3789

Published: 2013

Journal Articles

Safe and Effective Adoptive T-Cell Receptor Transfer with a High Affinity Single Chain p53(264–272)-Specific TCR

Hakim Echchannaoui, PhD, Jutta Petschenka, PhD student, Edite Antunes, Matthias Theobald, MD, PhD

Blood (2012) 120 (21): 4226.

https://doi.org/10.1182/blood.V120.21.4226.4226

Published: 2012

Journal Articles

Functionally Altered GPI-Anchor Negative Treg Following Alemtuzumab-Based T-Cell Depletion Are Associated with Acute Gvhd.

Eva M Wagner, Lukas A Schaefer, Tobias Bopp, Matthias Theobald, MD, PhD, Wolfgang Herr, MD, Ralf G Meyer

Blood (2012) 120 (21): 3059.

https://doi.org/10.1182/blood.V120.21.3059.3059

Published: 2012

Journal Articles

Impact of Prophylactic CD8-Depleted Donor-Lymphocyte Infusions After Allogeneic Hematopoietic Stem Cell Transplantation and Alemtuzumab Mediated T-Cell Depletion,

Eva M Wagner, MD, Daniela Wehler, MD, Karin Kolbe, MD, Matthias Theobald, MD, PhD, Wolfgang Herr, MD, Ralf G Meyer, MD

Blood (2011) 118 (21): 4109.

https://doi.org/10.1182/blood.V118.21.4109.4109

Published: 2011

Journal Articles

Autologous Blood Stem Cell Transplantation Results In Better Relapse-Free Survival Than Consolidation Chemotherapy: Results of a HOVON/SAKK Phase III Trial In 519 AML Patients In First Complete Remission

Edo Vellenga, MD, PhD, Wim van Putten, MD, PhD, Gert J. Ossenkoppele, MD, PhD, Martin Fey, MD, Jurgen Kuball, MD, PhD, Matthias Theobald, MD, PhD, Jan J. Cornelissen, MD, PhD, Peter Huijgens, MD, PhD, Johan Maertens, Alois Gratwohl, MD, Martyn Ronald Schaafsma, MD, PhD, Markus G Manz, MD, Carlos Graux, MD, PhD, Bob Lowenberg, MD, PhD

Blood (2010) 116 (21): 367.

https://doi.org/10.1182/blood.V116.21.367.367

Published: 2010

Journal Articles

Biomarkers of Cartilage and Bone Damage as a Measure of Joint Damage in Haemophilia.

Nathalie W.D. Jansen, PhD, Goris Roosendaal, MD, PhD, Bjorn Lundin, MD, PhD, Lily Heijnen, MD, PhD, Matthias Theobald, MD, PhD, Johannes W.J. Bijlsma, MD, PhD, Floris P.J.G. Lafeber, PhD

Blood (2008) 112 (11): 1214.

https://doi.org/10.1182/blood.V112.11.1214.1214

Published: 2008

NARROW

Combined Targeting of the Menin-MLL1 Chromatin Complex and FLT3 As a Novel Therapeutic Concept Against NPM1 Mutant or MLL -Rearranged AML with Mutated FLT3

Ruxolitinib Inhibits Toll-like Receptor or GM-CSF, but Not TREM-1 Mediated Neutrophil Activation

How to Identify Patients for Treg DLI - Treg Subsets in Gvhd As Biomarker for Successful Treg DLI

Idelalisib Impairs TREM-1 Mediated Neutrophil Inflammatory Responses

Identification of Baseline Characteristics That Predict Good Outcome of Allogeneic Hematopoietic Cell Transplantation in Young Chronic Lymphocytic Leukemia Patients - a Retrospective Analysis from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation.

Targeting Aberrant Ncam (neural cell adhesion molecule; CD56) Expression in Acute Myeloid Leukemia

Interfering with Arginine Metabolism As a New Treatment Strategy for Multiple Myeloma

The Impact of NFAT Inhibition on Neutrophil Antifungal Defense and Myelopoiesis in Cyclosporine A Treated and NFATc1 LysM Mice

Transcutaneous Immunization with a Solid Nanoscopic Imiquimod Suspension Enhances Tumor Rejection

Impact of Donor Type on Outcome after Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia Patients: Analysis of the German-Austrian Acute Myeloid Leukemia Study Group (AMLSG)

Neuroendocrine Regulation Of The IL-27-Dependent Immune Response In Macrophages

Treatment Results In Acute Myeloid Leukemia Over a Time Period Of 20 Years: Analysis Of The German-Austrian Acute Myeloid Leukemia Study Group (AMLSG)

Gene Therapy With a High-Affinity Single-Chain p53-Specific TCR Mediates Potent Anti-Tumor Response Without Inducing Gvhd In Vivo

Follow Up On CD8-Depleted Donor-Lymphocyte Infusions After T-Cell Depleted Allogeneic Hemopoietic Stem Cell Transplantation

Expression Of FLT3-ITD Dysregulates The DBC1-Sirt1-p53 Signaling and Promotes Therapy Resistance

Safe and Effective Adoptive T-Cell Receptor Transfer with a High Affinity Single Chain p53(264–272)-Specific TCR

Functionally Altered GPI-Anchor Negative Treg Following Alemtuzumab-Based T-Cell Depletion Are Associated with Acute Gvhd.

Impact of Prophylactic CD8-Depleted Donor-Lymphocyte Infusions After Allogeneic Hematopoietic Stem Cell Transplantation and Alemtuzumab Mediated T-Cell Depletion,

Autologous Blood Stem Cell Transplantation Results In Better Relapse-Free Survival Than Consolidation Chemotherapy: Results of a HOVON/SAKK Phase III Trial In 519 AML Patients In First Complete Remission

Biomarkers of Cartilage and Bone Damage as a Measure of Joint Damage in Haemophilia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only